Here are relevant reports on : heart-failure-devices-market
-
Structural Heart Devices Market by Product (Heart Valve Devices Transcatheter and Surgical), Occluders, Closure and Delivery Systems, Annuloplasty Rings, Accessories, Procedure (Replacement(TAVR/TAVI), Repair & End-Users - Global Forecast to 2029
The global structural heart devices market, valued at US$14.93 billion in 2023, stood at US$16.31 billion in 2024 and is projected to advance at a resilient CAGR of 9.5% from 2024 to 2029, culminating in a forecasted valuation of US$25.69 billion by the end of the period. The several main factors driving the market of structural heart devices reflect advances in healthcare technology and patient demographics. In this regard, the incidence and prevalence of structural heart diseases, including aortic stenosis and mitral regurgitation, increase with aging populations across the globe.
- Published: December 2024
- Price: $ 4950
- TOC Available:
-
Electroceuticals Market / Bioelectric Medicine Market by Product (Cardiac Pacemakers, ICD, Cochlear Implant, Neuromodulation (Deep Brain Stimulation)), Type (Implantable, Non-Invasive), Application (Arrhythmia, Heart Failure, Epilepsy) & Region - Global Forecast to 2029
The global electroceuticals market, valued at US$21.9 billion in 2023, stood at US$23.9 billion in 2024 and is projected to advance at a resilient CAGR of 7.0% from 2024 to 2029, culminating in a forecasted valuation of US$33.6 billion by the end of the period. Growth of the overall market is largely driven by the increasing incidence of cardiovascular, hearing loss and neurological disorders, increasing research in these field of disorders, and rising awareness regarding electroceuticals devices.
- Published: March 2024
- Price: $ 4950
- TOC Available:
-
Prosthetic Heart Valve Market by Type (Transcatheter Heart Valve, Tissue Heart Valve, and Mechanical Heart Valve), and Region (North America, Europe, Asia-Pacific, and RoW) - Global Forecast to 2022
The prosthetic heart valves market is growing at a CAGR of 12.9%. Some of the prominent players in the market are Medtronic plc (Ireland), Edwards Lifesciences Corporation (U.S.), Boston Scientific Corporation (U.S.), St. Jude Medical, Inc. (an Abbott Laboratories Company) (U.S.), LivaNova PLC (U.K.), Symetis SA (Switzerland), Jenavalve Technology, Inc. (Germany), CryoLife, Inc. (U.S.), TTK Healthcare Limited (India), Colibri Heart Valve, LLC (U.S.), Lepu Medical Technology Co., Ltd. (China), and Braile Biomédica (Brazil) are the prominent players in the global prosthetic heart valves market.
- Published: June 2017
- Price: $ 4950
- TOC Available:
-
US Interventional Cardiology Devices Market by Type (Stents, Balloons, Structural Heart, Angio Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration, Guidewire, Introducer Sheaths), End User (Hospitals, Cardiac Centers) - Forecast to 2031
The US interventional cardiology devices market, valued at USD 12.09 billion in 2025, stood at USD 12.82 billion in 2026 and is projected to advance at a resilient CAGR of 6.7% from 2026 to 2031, culminating in a forecasted valuation of USD 17.75 billion by the end of the period. The market is driven by the increasing number of cases of heart and blood vessel diseases, especially coronary artery disease and heart valve disorders, and the aging population.
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
Heart Valves Repair Market by Procedure Type (Heart Valve Repair (Surgical, Percutaneous, Transcatheter) & Heart Valve Replacement (Type (Mechanical Valve, Bioprosthetic Valve, Tavi) & Position (Mitral Valve, Aortic Valve)) - Global Forecast to 2020
Heart valve disease occurs when one or more heart valves fail to open and close properly. This can affect the ability of heart to pump blood. Heart valve diseases can be congenital (at birth) or acquired later in life due to age-related changes, infections, heart attacks, calcific degeneration, heart disease or damage. There are mainly two types of problems that can disrupt blood flow through the valves, namely, regurgitation (incompetence) or stenosis (narrowing). Some valve problems are minor and do not need treatment while others might require medicines, lifestyle changes, and/or surgical procedures to repair or replace the valve. If not treated, advanced heart valve disease can cause heart failure, stroke, blood clots, or death due to sudden cardiac arrest (SCA).
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Cardiac Tissue Engineering Market by Material (Scaffold, Stem cells), Product (Heart Valve, Vascular Grafts), Applications (MI,Congenital Heart Disease), End-User (Hospitals & Clinics, Academics & Research Institutes) - Global Forecast to 2029
The global cardiac tissue engineering market, valued at US$546.8 million in 2023, stood at US$621.2 million in 2024 and is projected to advance at a resilient CAGR of 16.5% from 2024 to 2029, culminating in a forecasted valuation of US$1,333.6 million by the end of the period. This growth is driven by increased demand for regenerative medicine, advancements in 3D bioprinting, and rising cardiovascular disease prevalence.
- Published: September 2024
- Price: $ 4950
- TOC Available:
-
Cardiac Surgery Instruments Market by Product (Clamps, Forceps, Scalpel, Scissors, Needle Holder), Application (Coronary Artery Bypass Graft, Heart Valve Surgery, Pediatric Surgery, Heart Transplant), & End User (Hospital, ASC) - Global Forecast to 2022
The cardiac surgery instruments market is expected to reach USD 1.63 Billion by 2022 from USD 1.16 Billion in 2017, at a CAGR of 7.1%. The market is mainly driven by factors such as high incidence of cardiac diseases, growing prevalence of cardiac conditions and the subsequent increase in the number of surgical procedures, rising geriatric population, and growing investments, funds, and grants by government bodies worldwide.
- Published: May 2017
- Price: $ 4950
- TOC Available:
-
Medical Bionic Implant /Artificial Organs Market - (Vision Bionics/Bionic Eye, Brain Bionics, Heart Bionics/Artificial Heart, Orthopedic Bionics and Ear Bionics) Trends and Global Forecasts to 2017
Bionics is mechanical/electronic replacement or enhancement of organs/parts of living organisms. The medical bionic implants market is a potentially growing one with a global market of $12.67 billion in 2012. It is expected to grow at a CAGR of 7.1% to reach $17.82 billion in 2017.
- Published: November 2012
- Price: $ 4950
- TOC Available:
-
Well Intervention Market by Service (Logging and Bottomhole Survey, Tubing/Packer Failure and Repair, Stimulation), Intervention (Light, Medium, Heavy), Application (Onshore, Offshore) Well (Horizontal, Vertical), and Region - Global Forecast to 2029
The Well Intervention market is projected to reach USD 11.3 billion by 2029, at a CAGR of 4.2% during the forecast period. Some of the major players in the Well Intervention market are Halliburton (US), SLB (US), Baker Hughes (US), Weatherford (US), Forum Energy Technologies, Inc. (US), Archer (US), Expro Group (US), Trican (Canada), Patterson -UTI (US), and Interventek Subsea Engineering (UK) . The major strategies adopted by these players include sales contracts and agreements.
- Published: June 2024
- Price: $ 4950
- TOC Available:
-
Focused Ion Beam Market by Ion Source (Ga+ Liquid Metal, Plasma, Gas Field), Application (Failure Analysis, Nanofabrication, Device Modification, Circuit Edit, Counterfeit Detection), Vertical and Region - Global Forecast to 2028
The global focused ion beam market is expected to grow from USD 1.3 billion in 2023 to USD 1.8 billion by 2028, at a compound annual growth rate (CAGR) of 7.0% during the forecast period.The Key Players Thermo Fisher Scientific Inc. (US); ZEISS International (Germany); Hitachi, Ltd. (Japan); JEOL Ltd. (Japan); TESCAN ORSAY HOLDING, a.s. (Czech Republic); Eurofins Scientific (Luxembourg); A&D Company, Limited (Japan); Veeco Instruments Inc. (US); Raith GmbH (Germany); and FOCUS GmbH (Germany).
- Published: December 2022
- Price: $ 4950
- TOC Available:
Records 1 to 10 of 50
